![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » California Introduces Bill to Prohibit Prescription Drug Coupons
California Introduces Bill to Prohibit Prescription Drug Coupons
![](https://www.fdanews.com/ext/resources/test/Drug-Images3/CuttingMoney.gif?t=1433878515&width=430)
March 3, 2017
A California lawmaker introduced a bill that would prohibit pharmaceutical companies from issuing certain prescription drug discounts or coupons to consumers in the state.
The bill would make it a crime to offer rebates, vouchers or any reduction in an individual’s out-of-pocket expenses for a product, including their insurance copayments and deductibles — as long as there is a cheaper alternative designated by the FDA as therapeutically interchangeable.
The proposed bill would not ban rebates required under a REMS program.
Upcoming Events
-
21Oct